Nature World News Antibody Gets High Marks for Asthma Control MedPage Today PHILADELPHIA -- Asthma exacerbations decreased by 87% in patients treated with an investigational agent that targets the interleukin-4 (IL-4) receptor, results of a placebo-controlled phase II trial showed. Dupilumab was associated with an exacerbation ... New Drug May Help Some Asthmatics, Study Finds New York Times Encouraging News For Asthma Patients – The New England Journal of Medicine ..
See the original article here:
Antibody Gets High Marks for Asthma Control - MedPage
Brak komentarzy:
Prześlij komentarz